In this study, we further revealed that Sac/Val treatment downregulated the levels of IL-17 in both myocardial tissue and peripheral blood, and decreased the infiltration of Th17 in myocardial tissue of mice with myocarditis. The gene discussed is IL17A; the disease is myocarditis.